Anticancer Drugs Oncology Pharmacology Physiotherapy Romidepsin


In this article we will discuss Romidepsin (Dosage Overview)

In this article, we will discuss Romidepsin (Dosage Overview). So, let’s get started.


Romidepsin is indicated for treatment of cutaneous T-cell lymphoma (CTCL)
in patients who have received at least one prior systemic therapy.


Dosing Information
The recommended dose of romidepsin is 14 mg/m² administered intravenously over a 4-hour period on days 1, 8 and 15 of a 28-day cycle. Cycles should be repeated every 28 days provided that the patient continues to
benefit from and tolerates the therapy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.